Filippo Cattazzo

411 total citations
26 papers, 254 citations indexed

About

Filippo Cattazzo is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Filippo Cattazzo has authored 26 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Filippo Cattazzo's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (8 papers) and Cardiovascular Function and Risk Factors (3 papers). Filippo Cattazzo is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (8 papers) and Cardiovascular Function and Risk Factors (3 papers). Filippo Cattazzo collaborates with scholars based in Italy, United Kingdom and United States. Filippo Cattazzo's co-authors include Cristiano Fava, Giuseppe Lippi, Martina Montagnana, Zhide Hu, Andrea Dalbeni, Alessandro Mantovani, Michele Bevilacqua, Rosa Lombardi, Chiara Zusi and Pietro Minuz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Filippo Cattazzo

22 papers receiving 249 citations

Peers

Filippo Cattazzo
Tae Hun Kim South Korea
Filippo Cattazzo
Citations per year, relative to Filippo Cattazzo Filippo Cattazzo (= 1×) peers Tae Hun Kim

Countries citing papers authored by Filippo Cattazzo

Since Specialization
Citations

This map shows the geographic impact of Filippo Cattazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Cattazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Cattazzo more than expected).

Fields of papers citing papers by Filippo Cattazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Cattazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Cattazzo. The network helps show where Filippo Cattazzo may publish in the future.

Co-authorship network of co-authors of Filippo Cattazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Cattazzo. A scholar is included among the top collaborators of Filippo Cattazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Cattazzo. Filippo Cattazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalbeni, Andrea, Filippo Cattazzo, Bernardo Stefanini, et al.. (2025). What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?. Expert Review of Gastroenterology & Hepatology. 19(4). 389–398.
2.
Bevilacqua, Michele, Simone Romano, Filippo Cattazzo, et al.. (2025). Atezolizumab plus Bevacizumab does not cause subclinical cardiotoxicity evaluated by Left-Ventricular Global Longitudinal Strain. Digestive and Liver Disease. 57. S66–S66.
3.
Dalbeni, Andrea, Filippo Cattazzo, A. Auriemma, et al.. (2025). Glucagon‐Like Peptide‐1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta‐Analysis and Clinical Decision Framework. Cancer Medicine. 14(24). e71434–e71434.
5.
Bevilacqua, Michele, et al.. (2024). Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis. Digestive and Liver Disease. 56(9). 1522–1528. 1 indexed citations
6.
Dalbeni, Andrea, Filippo Cattazzo, Antonio Vella, et al.. (2023). Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients. Cancers. 15(9). 2406–2406. 10 indexed citations
7.
Dalbeni, Andrea, Sara Romeo, Filippo Cattazzo, et al.. (2023). Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population. International Journal of Molecular Sciences. 24(21). 15837–15837. 4 indexed citations
8.
Dalbeni, Andrea, et al.. (2023). Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients. Digestive and Liver Disease. 56(3). 477–483. 6 indexed citations
9.
Cattazzo, Filippo, Martino F. Pengo, Alice Giontella, et al.. (2023). Effect of Continuous Positive Airway Pressure on Glucose and Lipid Profiles in Patients With Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Archivos de Bronconeumología. 59(6). 370–376. 20 indexed citations
10.
Dalbeni, Andrea, Filippo Cattazzo, Michele Bevilacqua, et al.. (2023). The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study. PLoS ONE. 18(2). e0281813–e0281813. 4 indexed citations
11.
Bevilacqua, Michele, Francesco Dima, Filippo Cattazzo, et al.. (2023). Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia. Internal and Emergency Medicine. 18(5). 1397–1404. 2 indexed citations
12.
Lombardi, Rosa, Filippo Cattazzo, Alessandro Mantovani, et al.. (2023). Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies. Journal of Thrombosis and Thrombolysis. 57(2). 330–336. 5 indexed citations
13.
Mantovani, Alessandro, et al.. (2022). MAFLD and CKD: An Updated Narrative Review. International Journal of Molecular Sciences. 23(13). 7007–7007. 30 indexed citations
14.
Cattazzo, Filippo, Rosa Lombardi, Michele Bevilacqua, et al.. (2022). Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension. Nutrition Metabolism and Cardiovascular Diseases. 32(12). 2839–2847. 5 indexed citations
15.
Cattazzo, Filippo, Francesco Inglese, Andrea Dalbeni, et al.. (2022). Performance of non-invasive respiratory function indices in predicting clinical outcomes in patients hospitalized for COVID-19 pneumonia in medical and sub-intensive wards: a retrospective cohort study. Internal and Emergency Medicine. 17(4). 1097–1106. 5 indexed citations
16.
Bevilacqua, Michele, Filippo Cattazzo, Andrea Dalbeni, et al.. (2021). Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19–Related Disease. The American Journal of Cardiology. 165. 109–115. 4 indexed citations
17.
Dalbeni, Andrea, Alessandro Giollo, Michele Bevilacqua, et al.. (2020). Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients. Hypertension Research. 43(9). 922–928. 20 indexed citations
18.
Fava, Cristiano, Filippo Cattazzo, Zhide Hu, Giuseppe Lippi, & Martina Montagnana. (2019). The role of red blood cell distribution width (RDW) in cardiovascular risk assessment: useful or hype?. Annals of Translational Medicine. 7(20). 581–581. 80 indexed citations
19.
Fava, Cristiano, et al.. (2019). Unusual presentation of primary aldosteronism with advanced target organ damage: A case report. SHILAP Revista de lepidopterología. 14(7). 814–818. 3 indexed citations
20.
Tagetti, Angela, Alice Giontella, Michele Bevilacqua, et al.. (2019). SUBCLINICAL TARGET ORGAN DAMAGE IN A SAMPLE OF CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. Journal of Hypertension. 37. e201–e201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026